These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17909314)

  • 21. Efficacy and safety of dapoxetine in treatment of premature ejaculation: an evidence-based review.
    Russo A; Capogrosso P; Ventimiglia E; La Croce G; Boeri L; Montorsi F; Salonia A
    Int J Clin Pract; 2016 Sep; 70(9):723-33. PubMed ID: 27456527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy and tolerability of dapoxetine in the treatment of premature ejaculation].
    Yang L; Luo L; Chen XF; Fan JH; Liu RM; Wang XN; Nan XY; Zhang Y; Lin XF; Wang MZ; Xing JP; Yang ZS; Jian BL; He H; Wu DP; He DL
    Zhonghua Nan Ke Xue; 2015 Oct; 21(10):892-5. PubMed ID: 26665676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dapoxetine: in premature ejaculation.
    Hoy SM; Scott LJ
    Drugs; 2010 Jul; 70(11):1433-43. PubMed ID: 20614950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dapoxetine for premature ejaculation.
    Drug Ther Bull; 2014 Mar; 52(3):30-3. PubMed ID: 24627135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Combination of Dapoxetine and Behavioral Treatment Provides Better Results than Dapoxetine Alone in the Management of Patients with Lifelong Premature Ejaculation.
    Cormio L; Massenio P; La Rocca R; Verze P; Mirone V; Carrieri G
    J Sex Med; 2015 Jul; 12(7):1609-15. PubMed ID: 26077706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re: Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study.
    Seftel AD
    J Urol; 2014 Apr; 191(4):1077-8. PubMed ID: 24703142
    [No Abstract]   [Full Text] [Related]  

  • 27. [Premature ejaculation].
    Porst H
    Urologe A; 2009 Jun; 48(6):663-74. PubMed ID: 19557470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An overview of pharmacotherapy in premature ejaculation.
    Porst H
    J Sex Med; 2011 Oct; 8 Suppl 4():335-41. PubMed ID: 21967395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials.
    Pryor JL; Althof SE; Steidle C; Rosen RC; Hellstrom WJ; Shabsigh R; Miloslavsky M; Kell S;
    Lancet; 2006 Sep; 368(9539):929-37. PubMed ID: 16962882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results from a prospective observational study of men with premature ejaculation treated with dapoxetine or alternative care: the PAUSE study.
    Mirone V; Arcaniolo D; Rivas D; Bull S; Aquilina JW; Verze P;
    Eur Urol; 2014 Apr; 65(4):733-9. PubMed ID: 23993257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study.
    McMahon CG; Giuliano F; Dean J; Hellstrom WJ; Bull S; Tesfaye F; Sharma O; Rivas DA; Aquilina JW
    J Sex Med; 2013 Sep; 10(9):2312-25. PubMed ID: 23845016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical therapy for premature ejaculation.
    Montorsi F; Salonia A
    Lancet; 2006 Sep; 368(9539):894-6. PubMed ID: 16962861
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of premature ejaculation in the Asia-Pacific region: results from a phase III double-blind, parallel-group study of dapoxetine.
    McMahon C; Kim SW; Park NC; Chang CP; Rivas D; Tesfaye F; Rothman M; Aquilina J;
    J Sex Med; 2010 Jan; 7(1 Pt 1):256-68. PubMed ID: 19878447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment benefit of dapoxetine for premature ejaculation: results from a placebo-controlled phase III trial.
    Kaufman JM; Rosen RC; Mudumbi RV; Tesfaye F; Hashmonay R; Rivas D
    BJU Int; 2009 Mar; 103(5):651-8. PubMed ID: 19021601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of dapoxetine treatment success in lifelong premature ejaculation patients with penile sympathetic skin response.
    Kati B; Ay H
    Andrologia; 2018 Nov; 50(9):e13076. PubMed ID: 29952430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Dapoxetine for the treatment of premature ejaculation: a meta-analysis of randomized clinical trials on intravaginal ejaculatory latency time, patient-reported outcomes, and adverse events.
    Yue FG; Dong L; Hu TT; Qu XY
    Urology; 2015 Apr; 85(4):856-61. PubMed ID: 25817107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Premature ejaculation and pharmaceutical company-based medicine: the dapoxetine case.
    Waldinger MD; Schweitzer DH
    J Sex Med; 2008 Apr; 5(4):966-997. PubMed ID: 18371047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective randomized study to compare pelvic floor rehabilitation and dapoxetine for treatment of lifelong premature ejaculation.
    Pastore AL; Palleschi G; Leto A; Pacini L; Iori F; Leonardo C; Carbone A
    Int J Androl; 2012 Aug; 35(4):528-33. PubMed ID: 22320846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Take a PAUSE for the premature ejaculation cause.
    Giuliano F
    Eur Urol; 2014 Apr; 65(4):740-1. PubMed ID: 24091022
    [No Abstract]   [Full Text] [Related]  

  • 40. Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries.
    Buvat J; Tesfaye F; Rothman M; Rivas DA; Giuliano F
    Eur Urol; 2009 Apr; 55(4):957-67. PubMed ID: 19195772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.